The product is intended for treating cases of jaundice in children. Its formula works to reduce the level of bilirubin in the blood through inhibition of the normal enterohepatic cycling of unconjugated bilirubin. In addition, it works to improve bowel movement without causing diarrhea, which contributes to increasing the excretion of bilirubin. The formula reduces the damage expected from high levels of bilirubin on the child’s brain and body (neurotoxicity), and the formula also works to prevent collateral damage caused by other treatment methods, such as phototherapy, which works on hypomagnesimia and thus increases the possibility of neurotoxicity and brain damage.